was seen in 2014 (68.6%) and the least in 2016 (9.4%). The Chlamydia-specific antigen positivity in the years 2015 (13.4%) and 2016 (9.4%) was significantly less than in all the previous study years (P < 0.0001); however, there was no significant difference between the antigen positivity of years 2015 and 2016 (P = 0.4715) [ Table 2 and Figure 1 ].
Based on the clinical diagnosis, patients were divided into four groups -trachoma group; follicular, acute, or chronic conjunctivitis group; keratoconjunctivitis group; and a group of other eye manifestationssuggestive of chlamydial infections. The difference between antigen positivity in patients having "trachoma" and those having "other eye manifestations" was statistically significant (P = 0.0274) [ Table 3 and Figure 2 ].
conclusIon
Undiagnosed and hence improperly managed chronic ocular chlamydial infections continue to be a burden in terms of ocular morbidity and vision loss. Stringent surveillance in the coming years is needed to know its burden both in community and in the referral centers with varied ocular manifestations.
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